reports
Garvit Bhandari
- Garvit Bhandari
Medtronic Plc. (NYSE: MDT) to Separate its Diabetes Business
On May 21, 2025, Medtronic plc (NYSE: MDT) announced plans to separate its Diabetes business into a separate, publicly traded company. The separation will occur via a two step transaction - an initial minority IPO carve-out followed by a split-off of the remaining stake. The separation will be tax-free for the shareholders and is expected to be completed in the next 18 months.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.